H35.20 Other non-diabetic proliferative retinopathy, unspecified eye

Name of the Condition

• Other non-diabetic proliferative retinopathy, unspecified eye

Summary

Other non-diabetic proliferative retinopathy, unspecified eye, refers to abnormal growth of new blood vessels in the retina of an unspecified eye that is not caused by diabetes. This condition can lead to vision impairment or loss due to retinal damage, scarring, or detachment. It is distinct from diabetic retinopathy and may result from other underlying factors affecting retinal blood vessels.

Causes

The condition arises from disruptions in retinal blood flow or oxygen supply, triggering abnormal vessel growth. Potential causes include chronic retinal ischemia, inflammation, or vascular occlusions unrelated to diabetes. In some cases, the exact trigger remains unclear, but it often involves underlying systemic or ocular conditions affecting retinal health.

Risk Factors

• Chronic systemic diseases (e.g., hypertension, sickle cell disease).
• Retinal vein or artery occlusions.
• Inflammatory or autoimmune disorders affecting the eye.
• Advanced age-related retinal changes.
• History of retinal trauma or surgery.

Symptoms

• Sudden or gradual vision loss.
• Blurred or distorted vision.
• Floaters or spots in the visual field.
• Difficulty with night vision or peripheral vision.
• In severe cases, pain or redness in the eye.

Diagnosis

Diagnosis requires a comprehensive eye examination, including dilated retinal evaluation, to assess neovascularization and retinal health. Imaging studies such as fluorescein angiography or optical coherence tomography (OCT) may be used to confirm the presence and extent of abnormal blood vessel growth. The unspecified eye designation indicates the condition is documented without specifying the right or left eye.

Treatment Options

Treatment focuses on addressing the underlying cause and preventing further retinal damage. Options may include laser photocoagulation to reduce abnormal vessel growth, intravitreal injections of anti-VEGF agents to inhibit neovascularization, or surgical interventions like vitrectomy for severe cases involving retinal detachment or hemorrhage. Management is tailored to the individual’s condition and response to therapy.

Prognosis and Follow-Up

Prognosis depends on the severity of retinal involvement and timely intervention. Early detection and treatment can stabilize vision and prevent progression, but advanced cases may result in permanent vision loss. Regular follow-up with an ophthalmologist is essential to monitor retinal changes and adjust treatment as needed.

Complications

Potential complications include retinal detachment, vitreous hemorrhage, macular edema, and irreversible vision loss. Untreated or poorly managed cases may lead to significant visual impairment or blindness.

Lifestyle & Prevention

Managing underlying systemic conditions (e.g., controlling hypertension) and avoiding eye trauma can help reduce risk. Regular eye examinations are recommended for individuals with risk factors to detect early signs of retinal changes.

When to Seek Professional Help

Seek immediate medical attention for sudden vision loss, persistent floaters, or eye pain, as these may indicate worsening retinal damage or complications requiring urgent intervention.

Tips for Medical Coders

Use H35.20 for documentation of other non-diabetic proliferative retinopathy when the eye is not specified. Ensure clinical documentation supports the absence of diabetes as the cause and confirms neovascularization unrelated to diabetic retinopathy. Verify that the unspecified eye designation aligns with the provider’s documentation to avoid miscoding.